Gregory T. Went

Gregory T.
Went was the founder of CuraGen Corp., founded in 1992, where the title held was Director & Executive Vice President in 1999.
Dr. Went was the founder of Adamas Pharmaceuticals LLC, founded in 2000, holding the titles of Chairman, President & Chief Executive Officer.
Went was the founder of Tethys Bioscience, Inc., founded in 2002, with the title of Director from 2002 to 2009.
The current job is Chairman & Chief Executive Officer at Dextera Biosciences, Inc. since 2021, with employment starting in 2020.
Former jobs include Chairman & Chief Executive Officer at Neuromolecular Pharmaceuticals, Inc., Director at ParAllele BioScience, Inc., Director at Angelica Therapeutics, Inc., Managing Director at Halteres Associates LLC, and Advisor at Presidio Partners.
Education includes an undergraduate degree from Carnegie Mellon University in 1985 and a doctorate from the University of California, Berkeley in 1990.